Because the ECM is difficult to disrupt pharmacologically and CCN1 is stoichiometrically abundant, we asked if there are downstream protein–protein interactions (PPIs) essential for the observed CCN1high GBM phenotype. The gene discussed is CCN1; the disease is glioblastoma.